Randy W. Scott

2.2k total citations
37 papers, 1.8k citations indexed

About

Randy W. Scott is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Randy W. Scott has authored 37 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Immunology and 9 papers in Cancer Research. Recurrent topics in Randy W. Scott's work include Immune Response and Inflammation (11 papers), Protease and Inhibitor Mechanisms (9 papers) and S100 Proteins and Annexins (7 papers). Randy W. Scott is often cited by papers focused on Immune Response and Inflammation (11 papers), Protease and Inhibitor Mechanisms (9 papers) and S100 Proteins and Annexins (7 papers). Randy W. Scott collaborates with scholars based in United States, United Kingdom and New Zealand. Randy W. Scott's co-authors include Joffre Baker, M N Marra, C G Wilde, J L Snable, Dan Eaton, Barbara Bergman, Anil Bajpai, Michael McGrogan, Michael Collins and Charles J. Fisher and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Randy W. Scott

33 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Randy W. Scott United States 20 604 580 548 473 230 37 1.8k
Oliver Wiedow Germany 22 613 1.0× 380 0.7× 541 1.0× 224 0.5× 263 1.1× 37 1.9k
Ursula Bretz Japan 15 560 0.9× 494 0.9× 612 1.1× 219 0.5× 119 0.5× 24 1.8k
Lars Uhlin‐Hansen Norway 27 575 1.0× 713 1.2× 1.1k 2.0× 239 0.5× 131 0.6× 56 2.5k
Navjiwan Mann United States 10 1.6k 2.7× 280 0.5× 506 0.9× 380 0.8× 168 0.7× 11 2.4k
Jesús Merino Spain 24 1.1k 1.8× 219 0.4× 780 1.4× 86 0.2× 104 0.5× 73 2.1k
R M Marks United States 13 1.1k 1.7× 303 0.5× 862 1.6× 117 0.2× 59 0.3× 17 2.2k
Robert A. Reife United States 15 909 1.5× 333 0.6× 522 1.0× 72 0.2× 188 0.8× 18 2.1k
Patricia A. Temple United States 8 1.8k 3.0× 247 0.4× 929 1.7× 737 1.6× 59 0.3× 8 3.4k
Christine T. N. Pham United States 8 748 1.2× 315 0.5× 403 0.7× 95 0.2× 70 0.3× 11 1.5k
Katherine A. Owen United States 17 656 1.1× 546 0.9× 670 1.2× 229 0.5× 44 0.2× 27 2.1k

Countries citing papers authored by Randy W. Scott

Since Specialization
Citations

This map shows the geographic impact of Randy W. Scott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Randy W. Scott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Randy W. Scott more than expected).

Fields of papers citing papers by Randy W. Scott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Randy W. Scott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Randy W. Scott. The network helps show where Randy W. Scott may publish in the future.

Co-authorship network of co-authors of Randy W. Scott

This figure shows the co-authorship network connecting the top 25 collaborators of Randy W. Scott. A scholar is included among the top collaborators of Randy W. Scott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Randy W. Scott. Randy W. Scott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
3.
Scott, Randy W., et al.. (2022). A Case Report of Sjögren’s Syndrome Presenting With Autoimmune Hepatitis. Cureus. 14(3). e23464–e23464.
4.
Scott, Randy W., et al.. (2022). Management and Treatment of Grover’s Disease: A Case Report and Review of Literature. Cureus. 14(4). e24082–e24082. 1 indexed citations
5.
Scott, Randy W.. (2010). NovaMin Technology.. PubMed. 21(3). 59–60. 2 indexed citations
6.
Jin, Hua, Renqiang Yang, Scot A. Marsters, et al.. (1995). Protection against endotoxic shock by bactericidal/permeability-increasing protein in rats.. Journal of Clinical Investigation. 95(4). 1947–1952. 24 indexed citations
7.
Porat, Reuven, et al.. (1995). Effects of bactericidal/permeability-increasing protein on endotoxin-induced fever and Escherichia coli-induced shock in rabbits. Journal of Endotoxin Research. 2(1). 9–18. 4 indexed citations
8.
Fisher, Charles J., M N Marra, John E. Palardy, et al.. (1994). Human neutrophil bactericidal/permeability-increasing protein reduces mortality rate from endotoxin challenge. Critical Care Medicine. 22(4). 553–558. 92 indexed citations
10.
Rogy, Michael A., Hester S. A. Oldenburg, Steven E. Calvano, et al.. (1994). The role of bactericidal/permeability-increasing protein in the treatment of primate bacteremia and septic shock. Journal of Clinical Immunology. 14(2). 120–133. 22 indexed citations
11.
Wilde, C G, Peter M. Hawkins, Roger Coleman, et al.. (1994). Cloning and Characterization of Human Tissue Inhibitor of Metalloproteinases-3. DNA and Cell Biology. 13(7). 711–718. 30 indexed citations
12.
Opal, Steven M., et al.. (1994). Relative concentrations of endotoxin-binding proteins in body fluids during infection. The Lancet. 344(8920). 429–431. 71 indexed citations
13.
Stevens, Paul, Randy W. Scott, & Edward Shatzen. (1993). Recombinant Human Protease Nexin-1 Prevents Articular Cartilage-Degradation in the Rabbit. Birkhäuser Basel eBooks. 39. 173–177. 9 indexed citations
14.
Marra, M N, J L Snable, Steven R. Leong, et al.. (1993). Regulation of the Response to Bacterial Lipopolysaccharide by Endogenous and Exogenous Lipopolysaccharide Binding Proteins. Blood Purification. 11(2). 134–140. 3 indexed citations
15.
Marra, M N, et al.. (1992). The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin. The Journal of Immunology. 148(2). 532–537. 174 indexed citations
16.
Marra, M N, et al.. (1990). Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity.. The Journal of Immunology. 144(2). 662–666. 218 indexed citations
17.
McGrogan, Michael, Christian C. Simonsen, Randy W. Scott, et al.. (1988). Isolation of a complementary DNA clone encoding a precursor to human eosinophil major basic protein.. The Journal of Experimental Medicine. 168(6). 2295–2308. 49 indexed citations
18.
Cance, William G., William G. Dilley, Randy W. Scott, et al.. (1988). A potential new radiopharmaceutical for parathyroid imaging: Radiolabeled parathyroid-specific monoclonal antibody—II. Comparison of 125I- and 111In-labeled antibodies. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 15(3). 305–311. 4 indexed citations
19.
Cance, William G., William G. Dilley, Randy W. Scott, et al.. (1988). A potential new radiopharmaceutical for parathyroid imaging: Radiolabeled parathyroid-specific monoclonal antibody—I. Evaluation of 125I-labeled antibody in a nude mouse model system. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 15(3). 299–303. 4 indexed citations
20.
Low, David A., Randy W. Scott, Joffre Baker, & Dennis D. Cunningham. (1982). Cells regulate their mitogenic response to thrombin through release of protease nexin. Nature. 298(5873). 476–478. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026